David Roblin, CEO of Relation Therapeutics, said: "This financing is a significant milestone for Relation Therapeutics and underscores the confidence our investors have in our innovative approach to ...
Relation announces strategic collaboration with Novartis to advance therapeutics for atopic diseases
LONDON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Relation today announced a multi-program, strategic collaboration with Novartis to discover and advance novel targets for atopic diseases. Under the terms of ...
WALNUT CREEK, Calif.--(BUSINESS WIRE)--Relation Insurance Services, Inc. (“Relation”), one of the largest and fastest-growing national insurance agencies, announced today it acquired the assets of The ...
Relation and Novartis collaborate to advance treatments for atopic diseases using AI and immuno-dermatology expertise. Relation receives $55 million upfront, with potential milestones up to $1.7 ...
WALNUT CREEK, Calif.--(BUSINESS WIRE)--Relation Insurance Services, Inc. (“Relation”) announced today the promotions of Mark Kochner, Josh Bedgood, and Cary Taylor. “Mark, Josh, and Cary have ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback